{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:23:30Z","timestamp":1760243010970,"version":"build-2065373602"},"reference-count":60,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T00:00:00Z","timestamp":1427068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"USA NIH-NCI","award":["5RC2CA149001"],"award-info":[{"award-number":["5RC2CA149001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Signaling through the Fas\/Apo-1\/CD95 death receptor is known to affect  virus-specific cell-mediated immune (CMI) responses. We tested whether modulating  the Fas-apoptotic pathway can enhance immune responses to DNA vaccination or lymphocytic choriomeningitis virus (LCMV) infection. Mice were electroporated with plasmids expressing a variety of pro- or anti-apoptotic molecules related to Fas signaling and then either LCMV-infected or injected with plasmid DNA expressing SIV or HIV antigens. Whereas Fas or FasL knockout mice had improved CMI, down-regulation of Fas or FasL by shRNA or antibody failed to improve CMI and was accompanied by increases in regulatory T cells (Treg). Two \u201cadjuvant\u201d plasmids were discovered that significantly enhanced plasmid immunizations. The adjuvant effects of Fas-associated death domain (FADD) and of cellular FLICE-inhibitory protein (cFLIP) were consistently accompanied by increased effector memory T lymphocytes and increased T cell proliferation. This adjuvant effect was also observed when comparing murine infections with LCMV-Armstrong and its persisting variant LCMV-Clone 13. LCMV-Armstrong was cleared in 100% of mice nine days after infection, while LCMV-Clone 13 persisted in all mice. However, half of the mice pre-electroporated with FADD or cFLIP plasmids were able to clear LCMV-Clone 13 by day nine, and, in the case of cFLIP, increased viral clearance was accompanied by higher CMI. Our studies imply that molecules in the Fas pathway are likely to affect a number of events in addition to the apoptosis of cells involved in immunity.<\/jats:p>","DOI":"10.3390\/v7031429","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T12:17:00Z","timestamp":1427113020000},"page":"1429-1453","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modulation of SIV and HIV DNA Vaccine Immunity by  Fas-FasL Signaling"],"prefix":"10.3390","volume":"7","author":[{"given":"Jiabin","family":"Yan","sequence":"first","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1931-6147","authenticated-orcid":false,"given":"Juan","family":"Zapata","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Pauza","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Salvato","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2015,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical applications of DNA vaccines: Current progress","volume":"53","author":"Ferraro","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","article-title":"DNA vaccines: An historical perspective and view to the future","volume":"239","author":"Liu","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc2326","article-title":"DNA vaccines: Precision tools for activating effective immunity against cancer","volume":"8","author":"Rice","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature06537","article-title":"TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines","volume":"451","author":"Ishii","year":"2008","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.coi.2011.03.008","article-title":"Electroporation delivery of DNA vaccines: Prospects for success","volume":"23","author":"Sardesai","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1016\/j.vaccine.2009.07.005","article-title":"Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery","volume":"27","author":"Best","year":"2009","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/mt.2010.112","article-title":"Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques","volume":"18","author":"Hirao","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1182\/blood-2008-11-190520","article-title":"Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity","volume":"113","author":"Morrow","year":"2009","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e11021","DOI":"10.1371\/journal.pone.0011021","article-title":"GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates","volume":"5","author":"Loudon","year":"2010","journal-title":"PLoS One"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1073\/pnas.0911932107","article-title":"Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques","volume":"107","author":"Sui","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-4690-6-91","article-title":"Role of the Fas\/FasL pathway in HIV or SIV disease","volume":"6","author":"Poonia","year":"2009","journal-title":"Retrovirology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1038\/cddis.2010.77","article-title":"Mechanisms of HIV-associated lymphocyte apoptosis: 2010","volume":"1","author":"Cummins","year":"2010","journal-title":"Cell Death Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.4049\/jimmunol.178.9.5652","article-title":"Plasmid DNA vaccine-elicited cellular immune responses limit in vivo vaccine antigen expression through Fas-mediated apoptosis","volume":"178","author":"Greenland","year":"2007","journal-title":"J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1182\/blood-2008-06-165803","article-title":"CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses","volume":"112","author":"Greenland","year":"2008","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI200319069","article-title":"DNA vaccines and apoptosis: To kill or not to kill?","volume":"112","author":"Leitner","year":"2003","journal-title":"J. Clin. Invest."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/79470","article-title":"Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis","volume":"18","author":"Chattergoon","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/89289","article-title":"Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases","volume":"19","author":"Sasaki","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI200317293","article-title":"Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins","volume":"112","author":"Kim","year":"2003","journal-title":"J. Clin. Invest."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.immuni.2007.12.017","article-title":"Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity","volume":"28","author":"Hughes","year":"2008","journal-title":"Immunity"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.immuni.2007.12.015","article-title":"Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity","volume":"28","author":"Hutcheson","year":"2008","journal-title":"Immunity"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.immuni.2007.12.014","article-title":"Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction","volume":"28","author":"Weant","year":"2008","journal-title":"Immunity"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"Strasser","year":"2009","journal-title":"Immunity"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","article-title":"Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity","volume":"172","author":"Barouch","year":"2004","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.164.9.4635","article-title":"Increased DNA vaccine delivery and immunogenicity by electroporation in vivo","volume":"164","author":"Widera","year":"2000","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(98)00015-5","article-title":"The need for IgG2c specific antiserum when isotyping antibodies from C57BL\/6 and NOD mice","volume":"212","author":"Martin","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1073\/pnas.1009731107","article-title":"Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection","volume":"107","author":"Jin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1743-422X-10-52","article-title":"An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity","volume":"10","author":"Zapata","year":"2013","journal-title":"Virol. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.4049\/jimmunol.159.4.1703","article-title":"Peptide antigen or superantigen-induced down-regulation of TCRs involves both stimulated and unstimulated receptors","volume":"159","author":"Niedergang","year":"1997","journal-title":"J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/mt.2010.118","article-title":"IL-28B\/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques","volume":"18","author":"Morrow","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.4049\/jimmunol.1102756","article-title":"The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope","volume":"188","author":"Chuenarom","year":"2012","journal-title":"J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Pitisuttithum","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/nm.2528","article-title":"Moving ahead an HIV vaccine: To neutralize or not, a key HIV vaccine question","volume":"17","author":"Hope","year":"2011","journal-title":"Nat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(11)60877-5","article-title":"HIV prevention transformed: The new prevention research agenda","volume":"378","author":"Padian","year":"2011","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/10548","article-title":"Cancer therapy using a self-replicating RNA vaccine","volume":"5","author":"Ying","year":"1999","journal-title":"Nat. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.vaccine.2003.10.013","article-title":"Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines","volume":"22","author":"Leitner","year":"2004","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.vaccine.2006.08.007","article-title":"The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection","volume":"25","author":"Kojima","year":"2007","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1517\/14728222.2011.628937","article-title":"Targeting the Fas\/FasL signaling pathway in cancer therapy","volume":"16","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/hum.2007.059","article-title":"RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potency","volume":"19","author":"Huang","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.4049\/jimmunol.168.8.3965","article-title":"Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas\/Fas ligand-mediated fratricide","volume":"168","author":"Zuniga","year":"2002","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"982","DOI":"10.15252\/embr.201438463","article-title":"Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome priming","volume":"15","author":"Allam","year":"2014","journal-title":"EMBO Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/cdd.2010.69","article-title":"Enzymatically active single chain caspase-8 maintains T-cell survival during clonal expansion","volume":"18","author":"Leverrier","year":"2011","journal-title":"Cell Death Differ."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nm.2422","article-title":"Protective HIV-specific CD8+ T cells evade Treg cell suppression","volume":"17","author":"Elahi","year":"2011","journal-title":"Nat. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1086\/653707","article-title":"Increased regulatory T cell counts in HIV-infected nonresponders to hepatitis B virus vaccine","volume":"202","author":"Leal","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20011347","article-title":"Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses","volume":"196","author":"Kursar","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.161.9.4484","article-title":"Chemotactic activity of soluble Fas ligand against phagocytes","volume":"161","author":"Seino","year":"1998","journal-title":"J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: Putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1084\/jem.20132577","article-title":"Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection","volume":"211","author":"Kamphorst","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1128\/jvi.65.4.1863-1869.1991","article-title":"Molecular basis of viral persistence: A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence","volume":"65","author":"Salvato","year":"1991","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"Wilson","year":"2013","journal-title":"Science"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: Ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.it.2010.05.005","article-title":"FADD: A regulator of life and death","volume":"31","author":"Tourneur","year":"2010","journal-title":"Trends Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.celrep.2012.03.010","article-title":"Survival function of the FADD-CASPASE-8-cFLIP(L) complex","volume":"1","author":"Dillon","year":"2012","journal-title":"Cell Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1038\/cddis.2012.154","article-title":"The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-kappaB by TRAIL","volume":"3","author":"Grunert","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1083\/jcb.200401036","article-title":"NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP","volume":"166","author":"Kreuz","year":"2004","journal-title":"J. Cell Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e29231","DOI":"10.1371\/journal.pone.0029231","article-title":"Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and\/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults","volume":"7","author":"Kalams","year":"2012","journal-title":"PLoS One"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat. Rev. Immunol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/7\/3\/1429\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:43:49Z","timestamp":1760215429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/7\/3\/1429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,23]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3]]}},"alternative-id":["v7031429"],"URL":"https:\/\/doi.org\/10.3390\/v7031429","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2015,3,23]]}}}